IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q2 2023 Holdings

Filed 2023-08-11 | 11 holdings | $303.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karuna Therapeutics IncCOM48576A100$169.6M782,00855.9%
Vaxcyte Inc(PCVX)COM92243G108$39.6M793,03613.1%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$29.4M2,381,1969.7%
Inozyme Pharma IncCOM45790W108$20.4M3,661,5186.7%
Rallybio CorpCOM75120L100$13.6M2,404,6444.5%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$10.5M1,105,3093.5%
Fusion Pharmaceuticals IncCOM36118A100$7.3M1,560,9822.4%
Vigil Neuroscience Inc(VIGL)COM92673K108$5.3M560,5951.7%
Exscientia PLCADS30223G102$4.6M770,5001.5%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.4M1,891,4670.8%
Aligos Therapeutics IncCOM01626L105$721.7K743,2150.2%